Replimune stock tumbles 20% after FDA raises efficacy concerns
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Wall Street tumbles as hot inflation data feeds worries about Fed rate hikes
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
| Rider Explorations, Inc. (NASDAQ: REPL) | Delayed: 11.41 -0.7 (5.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.11 | 52 Week High | $1.45 | |||
| Open | $12.05 | 52 Week Low | $0.50 | |||
| Day High | $12.37 | P/E | N/A | |||
| Day Low | $11.41 | EPS | $0.00 | |||
| Volume | 1,200,940 | |||||
